What is a stock summary page? Click here for an overview.
Business Description
IXICO PLC
NAICS : 325412
SIC : 2836
ISIN : GB00BFXR4C20
Description
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.69 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.17 | |||||
| Beneish M-Score | -2.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -13.2 | |||||
| 3-Year FCF Growth Rate | -14.1 | |||||
| 3-Year Book Growth Rate | -6.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.42 | |||||
| 9-Day RSI | 23.21 | |||||
| 14-Day RSI | 30.24 | |||||
| 3-1 Month Momentum % | -2.29 | |||||
| 6-1 Month Momentum % | 16.36 | |||||
| 12-1 Month Momentum % | 44.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.85 | |||||
| Quick Ratio | 2.85 | |||||
| Cash Ratio | 1.14 | |||||
| Days Sales Outstanding | 84.49 | |||||
| Days Payable | 54.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 1.48 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.02 | |||||
| Operating Margin % | -36.46 | |||||
| Net Margin % | -34.7 | |||||
| FCF Margin % | -38.04 | |||||
| ROE % | -19.41 | |||||
| ROA % | -16.79 | |||||
| ROIC % | -23.38 | |||||
| 3-Year ROIIC % | -149.71 | |||||
| ROC (Joel Greenblatt) % | -182.13 | |||||
| ROCE % | -19.66 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.79 | |||||
| PB Ratio | 0.48 | |||||
| Price-to-Tangible-Book | 1.47 | |||||
| EV-to-EBIT | -3.55 | |||||
| EV-to-Forward-EBIT | -3.7 | |||||
| EV-to-EBITDA | -4.6 | |||||
| EV-to-Forward-EBITDA | -5.22 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-Forward-Revenue | 1.21 | |||||
| EV-to-FCF | -3.28 | |||||
| Price-to-GF-Value | 0.64 | |||||
| Price-to-Median-PS-Value | 0.37 | |||||
| Price-to-Net-Current-Asset-Value | 1.47 | |||||
| Earnings Yield (Greenblatt) % | -28.18 | |||||
| FCF Yield % | -25.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IXICO PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 6.814 | ||
| EPS (TTM) (€) | -0.049 | ||
| Beta | 0.28 | ||
| 3-Year Sharpe Ratio | -0.98 | ||
| 3-Year Sortino Ratio | -1.26 | ||
| Volatility % | 55.66 | ||
| 14-Day RSI | 30.24 | ||
| 14-Day ATR (€) | 0.002113 | ||
| 20-Day SMA (€) | 0.11055 | ||
| 12-1 Month Momentum % | 44.63 | ||
| 52-Week Range (€) | 0.071 - 0.16 | ||
| Shares Outstanding (Mil) | 92.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IXICO PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IXICO PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
IXICO PLC Frequently Asked Questions
What is IXICO PLC(FRA:PYPB)'s stock price today?
The current price of FRA:PYPB is €0.10. The 52 week high of FRA:PYPB is €0.16 and 52 week low is €0.07.
When is next earnings date of IXICO PLC(FRA:PYPB)?
The next earnings date of IXICO PLC(FRA:PYPB) is 2025-05-21 Est..
Does IXICO PLC(FRA:PYPB) pay dividends? If so, how much?
IXICO PLC(FRA:PYPB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers